Contact
Please use this form to send email to PR contact of this press release:
Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML
TO:
Please use this form to send email to PR contact of this press release:
Selvita Files IND Application for its Novel, Dual PIM/FLT3 Inhibitor in AML
TO: